Bullous Pemphigoid Following IgG/IgA Pemphigus: Possible Involvement of SGLT2 and DPP-4 Inhibitors
Ayano Ikeda, Naomi Tani, Norito Ishii, Hiroshi Koga, Yuichi Yoshida · 2026
Read Bullous Pemphigoid Following IgG/IgA Pemphigus: Possible Involvement of SGLT2 and DPP-4 Inhibitors by Ayano Ikeda, Naomi Tani, Norito Ishii, Hiroshi Koga, Yuichi Yoshida (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13254163.txt.
Description
Ayano Ikeda and colleagues report a layered blistering skin case in a 2026 case report. A 60-year-old woman developed redness and blisters on her back and upper arms. Tests confirmed IgG/IgA pemphigus, a rare blistering disease where the immune system attacks skin cell links, with antibodies to desmoglein 1.
During her course, she later developed bullous pemphigoid, a second blistering disease. She had taken two diabetes drugs, linagliptin for six years and tofogliflozin for five months. A drug stimulation test was positive for tofogliflozin and negative for linagliptin, so the authors consider possible drug involvement in the second disease.
Catalog record
| CREATOR | Ayano Ikeda, Naomi Tani, Norito Ishii, Hiroshi Koga, Yuichi Yoshida |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 8952 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |